Therefore, we have suggested that when IL17F expression levels are altered, genotypic variations in IL17F 7488A/G and IL17F 7383A/G polymorphisms might take part in JIA risk, hence, influencing JIA development. The gene discussed is IL17F; the disease is juvenile idiopathic arthritis.